Page 544 - medicina-integrativa_compress

CAPÍTULO 49 ENFERMEDAD INFLAMATORIA INTESTINAL 549

179. Sutherland L, Singlewton J, Sessions J, et al: Double-blind 186. Ernst E: St. John’s Wort supplements endanger the success of organ
placebo-controlled trial of metronidazole in Crohn’s disease. transplantation. Arch Surgery 137:316-319, 2002.
Gut 32:1071-1075, 1991. 187. Wacher VJ, Wong S, Wong HT: Peppermint oil enhances cyclosporine
180. Turunen UM, Farkkila MA, Hakala K, et al: Long-term treatment bioavailability in rats: Comparison with D-alpha-tocopheryl
of ulcerative colitis with ciprofloxacin: A prospective, double- poly(ethylene glycol 1000) succinate (TPGS) and keotconazole.
blind, placebo-controlled study. Gastroenterology 115:1072-1078, J Pharm Sci 91:77-90, 2002.
1998. 188. Homan van der Heide JJ, Bilo HJ, Tegzess AM, Donker AJ et al:
181. McFarland LV, Surawicz CM, Greenberg RN, et al: A randomized, The effects of dietary supplementation with fish oil on renal
placebo-controlled trial of Saccharomyces boulardii in combination function in cyclosporine-treated renal transplant recipients.
with standard antibiotics for Clostridium difficile disease. Transplantation 49:523-527, 1990.
JAMA 271:1913-1918, 1994. 189. Badalamenti S, Salerno F, Lorenzano E, et al: Renal effects of dietary
182. Rajnarayana K, Reddy MS, Vidyasagar J, et al: Study on the supplementation with fish oil in cyclosporine-treated liver transplant
influence of silymarin pretreatment on metabolism and disposition recipients. Hepatology 22:1695-1671, 1995.
of metronidazole. Arzneimittelforschung 54:109-113, 2004. 190. de Lorgeril M, Boissonnat P, Salen P, et al: The beneficial effect
183. Chuang CH, Sheu BS, Huang AH, et al: Vitamins C and E of dietary antioxidant supplementation on platelet aggregation and
supplements to lansoprazole-amoxacillin-metronidazole triple cyclosporine treatment in heart transplant patients. Transplantation
therapy may reduce the eradication rate of metronidazole-sensitive 58:193-195, 1994.
Helicobacter pylori infection. Helicobacter 7:310-316, 2002. 191. Agnusdei D, Bufalino L: Efficacy of ipriflavone in established
184. Lee AN, Wirth VP: Activation of autoimmunity following use osteoporosis and long-term safety. Calcif Tissue Int 61(Suppl 1):
of immunostimulatory herbal supplements. Arch Dermatol 140: S23-S27, 1997.
723-777, 2004. 192. Sandborn WJ: New concepts in anti-tumor necrosis factor therapy
185. Chu DT, Wong WL, Mavligit GM, et al: Immunotherapy for inflammatory bowel disease. Rev Gastroenterol Disord 5:10-18,
with Chinese medicinal herbs: II. Reversal of cyclophosphamide- 2005.
induced immune suppression by administration of fractionated 193. Parsi MA, Achkar JP, Richardson S, et al: Predictors of response to
Astragalus membranaceus in vivo. J Clin Lab Immunol 25:125-129, infliximab in patients with Crohn’s disease. Gastroenterology
1988. 123:707-713, 2002.

© Elsevier. Es una publicación MASSON. Fotocopiar sin autorización es un delito.